Purpose To evaluate the effect of epoetin alfa (EPO) on left ventricular hypertrophy in pre-dialysis patients.
目的评价慢性肾衰竭透析前患者使用阿法依泊汀(epoetinalfa,EPO,促红细胞生成素)对左心室肥大(leftventricularhypertrophy,LVH)的影响。
6ug/Kg groups) who were stableon hemodialysis over 3 months were included to evaluate thepharmacokinetics and security of darbepoetin alfa.
为了评估达依泊汀α在中国维持性血透患者中单次静脉给药的安全性和药代动力学特性,本课题对透析3个月以上稳定期慢性肾衰竭患者43例(分为0。
本网站所收集内容来自网友分享仅供参考,实际请以各学校实际公布信息为主!内容侵权及错误投诉:1553292129@qq.com
CopyRight © 2020-2025 优校网[www.youxiaow.com]版权所有 All Rights Reserved. 浙ICP备2024058711号